Recruiting NA INTERVENTIONAL 2-arm
NCT07326215
A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+
A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Chinese Critically Ill Patients: a Prospective Randomized Controlled Clinical Trial
Sponsor: Vantive Health LLC
Interventions
Invasive Mechanical Ventilation PrismaLung+
Updated 1 time since 2026 Last updated: Feb 12, 2026 Started: Dec 11, 2025 Primary completion: Aug 31, 2026 Completion: Aug 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07326215, this NA trial focuses on Acute Kidney Injury and Acute Respiratory Distress Syndrome and remains actively recruiting participants. Sponsored by Vantive Health LLC, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Vantive Health LLC
Data source: Vantive Health LLC
For direct contact, visit the study record on ClinicalTrials.gov .